Login
Toggle navigation
Videos
Categories
Trending
Shifting from Operator to Investor|Eva Alonso,Investor,Ribbit Capital
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Prior to Ribbit Capital, Eva served as an investor at Goldman Sachs
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Former Attorney General Bill Barr Discusses Trump, His Book, and His Time in Office|Bill Barr
00:10:00
Assessing International Markets: Evaluating Valuations, Interest Rates, and Investment Strategies | Euan Munro , CEO , Newton Investment Management .
00:10:00
Fran Horowitz on Revitalizing Abercrombie & Fitch: A Customer-Centric Approach | Fran Horowitz, CEO , Abercrombie & Fitch Co.
00:10:00
Cramer engages with AeroVironment CEO Wahid Nawabi, offering insights exclusively on CNBC PRO.
00:10:00
ABE Resources Explores High-Grade Lithium Potential at One-to-One Conference in Cape Town
00:10:00
After November 3, 2021, Mechanical Technologies rebrands as Soluna Holdings with CEO Michael Toporek and John leading the transition.
00:10:00
Understanding the Impact: A Deep Dive into Blockchain Applications in Real Estate | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
Group Eleven Resources' Zinc Exploration in Ireland: Key Developments and Prospects.
00:10:00
NT's Defence Destination: Nicole Manison's ADM Congress Speech | Nicole Manison - Minister of Northern Territory
00:10:00
Growth on Track: Puuilo’s Q1 2023 Success Amid Challenging Market Conditions | Juha Saarela, CEO, Puuil OYj.
00:10:00
Antipa Minerals: Advancing Exploration and Resource Development in the Patterson Province
00:10:00
Michael Roberts, CEO of HSBC USA and Americas, outlines key strategies for reshaping operations across the US and Americas.